Yüklüyor......
The Fraction Exhaled Nitric Oxide as a Biomarker of Asthma Control
INTRODUCTION AND OBJECTIVE: The main goal of asthma treatment is to achieve and maintain clinical control of the disease. The exhaled fraction nitric oxide (FeNO) level is a biomarker of T-helper cell type 2 (Th2) inflammation of the airways. Our objective was to determine whether the FeNO level can...
Kaydedildi:
| Yayımlandı: | Biomark Insights |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6357290/ https://ncbi.nlm.nih.gov/pubmed/30728712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1177271919826550 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|